Senti Biosciences Inc.

NASDAQ: SNTI · Real-Time Price · USD
1.58
0.06 (3.95%)
At close: Aug 18, 2025, 3:59 PM
1.62
2.53%
After-hours: Aug 18, 2025, 07:56 PM EDT

Senti Biosciences Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-14.73M -14.11M -610K -28.87M -11.2M -12.11M -18.69M -14.94M -18.7M -18.72M -18.22M -16.64M -11.55M -11.81M -10.9M -11.41M -206.07K -21M
Depreciation & Amortization
1.48M 926K 1.46M 1.46M 1.47M 1.46M 1.47M 1.81M 1.21M 929K 944K 1.03M 935K 1.01M 1.03M 872K 564K 540K
Stock-Based Compensation
1.53M 1.2M 605K 668K -776K 1.26M 2.06M 409K 3.43M 3.76M 4.22M 2.29M 9.22M 661K 735K 626K 562K 372K
Other Working Capital
630K n/a -2.16M -2.16M 2.99M -340K 4.14M 583K -243K -1.76M 4.77M -734K 5.6M 177K -400K 288K -727.49K n/a
Other Non-Cash Items
1.56M n/a -13.5M 21.32M -218K 1.41M 5.3M -5.79M -123K -661K -1.04M 295K -10.16M 12K 4.35M -460.71K -1.11K 12.1M
Deferred Income Tax
n/a n/a n/a n/a n/a n/a -3.17M 3.71M -380K n/a n/a n/a n/a n/a -4.34M 469.71K n/a n/a
Change in Working Capital
-1.38M -2.61M -1.46M -2.46M 2.38M 70K 5.98M -583K 880K -1.61M 5.09M 2.89M 5.86M 66K -2.85M 1.09M -727.49K 60K
Operating Cash Flow
-13.07M -14.05M -13.5M -7.87M -8.35M -11.68M -7.04M -15.38M -13.68M -16.3M -9.01M -10.14M -5.7M -10.06M -11.97M -8.8M -934.67K -8.37M
Capital Expenditures
-196K n/a -11K n/a n/a -15K -4K -1.86M -3.67M -6.51M -8.53M -14.2M -11.26M -7.38M -3.98M -932K -420K -206K
Cash Acquisitions
12K n/a n/a n/a n/a n/a 105K n/a n/a 2.99M n/a n/a n/a n/a n/a n/a n/a n/a
Purchase of Investments
n/a n/a n/a n/a n/a n/a 17.99M n/a n/a -17.99M -40.59M n/a n/a n/a -230M 230M -230M n/a
Sales Maturities Of Investments
n/a n/a n/a n/a n/a n/a -60M 23M 22M 15M n/a n/a n/a n/a n/a n/a n/a n/a
Other Investing Acitivies
n/a n/a n/a 60K n/a n/a 2.99M 23M 22M -2.99M -40.59M n/a n/a n/a 230M -230M -230M n/a
Investing Cash Flow
-184K n/a -11K 60K n/a -15K 101K 21.14M 18.33M -9.5M -49.12M -14.2M -11.26M -7.38M -3.98M -932K -230M -206K
Debt Repayment
n/a n/a -2.43M 2.43M n/a n/a -108K n/a -27K n/a n/a n/a 5.17M n/a n/a n/a n/a n/a
Common Stock Repurchased
n/a n/a n/a 10K n/a n/a -12.06B n/a 12.06B n/a 196K n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a -23.16K -3.89K -3.92K -965 n/a
Other Financial Acitivies
n/a -414K 4.67M 10K n/a n/a 664K -23K 308K -35K 876K -485K 113.44M -455K -25K 487K -160.51M 3.56M
Financial Cash Flow
1.01M -414K 51.29M 2.44M n/a n/a 556K -23K 281K -35K 876K -485K 118.61M -455K 23K 487K 232.03M 3.56M
Net Cash Flow
-12.23M -14.46M 37.77M -5.37M -8.35M -12.2M -3.5M 5.74M 4.94M -25.84M -57.25M -24.82M 101.66M -17.89M -15.93M -9.25M -24.92M -5.01M
Free Cash Flow
-13.27M -14.05M -13.52M -7.87M -8.35M -11.7M -7.04M -17.24M -17.34M -22.81M -17.54M -24.34M -16.95M -17.44M -15.96M -9.74M -1.35M -8.57M